Question

Will bimagrumab be approved for the treatment of obesity by the FDA or EMA by 2029?

1 comment1

Total Forecasters21

Community Prediction32.6%

Make a Prediction

50%

community: 32.6%

median 32.6%mean 33.3%

Authors:

casens

Opened:

Closes:

Scheduled resolution:

Health & Pandemics

Food and Drug Administration

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80.8%

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

59.7%

Comments

? comments

Authors:

casens

Opened:

Closes:

Scheduled resolution:

Health & Pandemics

Food and Drug Administration

Amgen stock falls as analysts mull over weight loss drug’s bone density data

CNBC•Nov 13, 2024

Scientific breakthrough to prevent negative side effects of weight loss drugs like Ozempic

Independent•Nov 14, 2024

New weight loss drug decreases appetite without nausea — and can even burn calories

New York Post•Nov 14, 2024

Learn more about Metaculus NewsMatch

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80.8%

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

59.7%